Increasingly potent immunosuppressive agents have dramatically reduced the incidence of
rejection of transplanted organs while increasing susceptibility to opportunistic infections
and cancer. This article reviews general concepts for the management of transplantation-
associated infections and discusses recent advances and challenges.